LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC (www.Goldberglawpc.com) reminds investors in Puma Biotechnology Inc. (“Puma” or the “Company”) (NYSE: PBYI), who purchased shares traceable to the Company’s Initial Public Offering (“IPO”) between July 23, 2014 and May 13, 2015, inclusive (the “Class Period”), of the August 3, 2015 deadline to file a motion to be appointed as lead plaintiff. If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldbe